I. Tumor/Cancer

We provide a comprehensive anti-tumor drug development platform to help accelerate your research and development process. The platform covers a variety of in vivo models, including xenograft models, syngeneic models, and spontaneous tumor models, which can be used to assess the efficacy, pharmacokinetic properties, and safety of candidate drugs. With extensive experience and specialized techniques, we can customize personalized models according to your specific needs, including but not limited to specific tumor types, routes of administration, and evaluation parameters. We are committed to providing you with high-quality data and professional experimental reports to efficiently promote your anti-tumor drug development.

1. Tumor 

1.1 Xenograft Tumor Models:

3. Tumor Images

 

II. Tumor Immunology

Tumor immunology studies the complex interplay between tumor antigens, host immune function, and tumor occurrence, development, and outcome, exploring the mechanisms of the host's immune response to tumors and how tumor cells escape immune surveillance, and is committed to developing immune-based tumor diagnosis and treatment strategies. We provide professional tumor immunology research services to deeply explore the identification and characterization of tumor antigens, the host immune system's recognition and response to tumors, and the impact of the tumor microenvironment on immune function. Specifically, we can help you study how tumor antigens affect tumor occurrence, development, and ultimate outcome, as well as the role of host immune function in tumor progression. Our services cover all aspects from experimental design to data analysis, aiming to provide you with high-quality data and comprehensive research support to promote breakthrough progress in your tumor immunology research.

Compound Inhibition of LPS-Induced Kynurenine (KYN) PK/PD Study in Murine Plasma: